2014
DOI: 10.1016/j.jneuroim.2014.02.003
|View full text |Cite
|
Sign up to set email alerts
|

New regulatory CD19+CD25+ B-cell subset in clinically isolated syndrome and multiple sclerosis relapse. Changes after glucocorticoids

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
32
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 49 publications
(33 citation statements)
references
References 44 publications
1
32
0
Order By: Relevance
“…The authors assumed that the observed high proportion of circulating CD19+CD25hig FoxP3high Bregs in MS patients during relapse was a compensatory peripheral response to the inflammatory circumstances of disease activity. The involvement of Bregs highly expressing FoxP3both in PB and CSF of MS patients is relevant to understanding the pathogenesis of MS and to the follow-up of diseases activity following immunosuppressive therapies [65]. Two less-studied Breg cell subsets (CD19+FoxP3+ and CD19+TGF-β+) were recently assessed in patients suffering from RA aiming to see if this was in association with disease activity and or the incidence of interstitial lung disease (ILD).…”
Section: Foxp3 Expression In Macrophagesmentioning
confidence: 99%
“…The authors assumed that the observed high proportion of circulating CD19+CD25hig FoxP3high Bregs in MS patients during relapse was a compensatory peripheral response to the inflammatory circumstances of disease activity. The involvement of Bregs highly expressing FoxP3both in PB and CSF of MS patients is relevant to understanding the pathogenesis of MS and to the follow-up of diseases activity following immunosuppressive therapies [65]. Two less-studied Breg cell subsets (CD19+FoxP3+ and CD19+TGF-β+) were recently assessed in patients suffering from RA aiming to see if this was in association with disease activity and or the incidence of interstitial lung disease (ILD).…”
Section: Foxp3 Expression In Macrophagesmentioning
confidence: 99%
“…15 Variously described as CD19 C CD38 high CD24 high or CD19 C CD25 high B cells, Breg in humans regulate functions of Th1 helper cells by producing immunosuppressive IL-10 or degranulation of perforin/granzyme molecules, respectively. 16,17 The antibody-independent regulation of T-cell functions by B cells is of great interest, largely because of the potential involvement of Breg in inflammation, autoimmune diseases and cancer. 18,19 Functional impairments of CD19 C CD38 high CD24 high Breg in systemic lupus erythematosus (SLE) patients 17 and an increased frequency of CD19 C CD25 high Breg during clinical manifestations of multiple sclerosis 16 illustrate their role in autoimmune diseases.…”
Section: Introductionmentioning
confidence: 99%
“…In humans, B reg cells have been phenotyped using CD24, IL-10, and Fox-P3 markers (35) (6, 34). As we were not able to identify reliable antibody clones that recognized CD24 in macaques we identified B reg cells as CD19 + CD25 high as previously described (5, 6).…”
Section: Resultsmentioning
confidence: 99%
“…They can act as antigen presenting cells and also as effector cells, producing antibodies, cytokines, adhesion molecules and chemokines (24). They have been reported to exert immune suppressive effects (5, 6) and to regulate T cell immunity in chronic hepatitis B infection and to impair CTL activity during HIV infection (7, 8). Both HIV and SIV infections lead to severe B-cell dysregulation and dysfunction in their respective hosts (9, 10).…”
Section: Introductionmentioning
confidence: 99%